GS
SRNE

Gagnon Securities’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Gagnon Securities’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-29,568
Closed -$112K – 97
2017
Q4 		$112K Sell
29,568
-2,018
-6% -$5.26K 0.04% 87
2017
Q3 		$54K Hold
31,586
– – 0.02% 92
2017
Q2 		$63 Buy
31,586
+20,470
+184% +$39.9K 0.02% 85
2017
Q1 		$44K Hold
11,116
– – 0.02% 91
2016
Q4 		$54K Hold
11,116
– – 0.02% 91
2016
Q3 		$86K Sell
11,116
-75
-0.7% -$505 0.04% 92
2016
Q2 		$63K Buy
11,191
+60
+0.5% +$383 0.03% 88
2016
Q1 		$60K Hold
11,131
– – 0.03% 85
2015
Q4 		$97K Buy
11,131
+130
+1% +$1.1K 0.04% 80
2015
Q3 		$92K Hold
11,001
– – 0.05% 81
2015
Q2 		$194K Buy
+11,001
New +$141K 0.08% 78

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
IP
Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $48.2B AUM 24.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return